Drug Profile
Research programme: HMG CoA reductase inhibitors - Tel Aviv University
Alternative Names: HMG CoA reductase inhibitors research programme - Tel Aviv UniversityLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Ramot at Tel Aviv University; Tel Aviv University
- Class
- Mechanism of Action HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Skin disorders
Most Recent Events
- 20 Dec 2005 No development reported - Clinical-Phase-Unknown for Skin disorders in Israel (unspecified route)
- 04 Apr 2001 This programme is available for licensing (http://www.tau.ac.il/ramot)
- 04 Apr 2001 Investigation in Skin disorders in Israel (Unknown route)